# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-23-000012
Filing Date
2023-08-09
Accepted
2023-08-08 17:56:35
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nktr-20230630.htm iXBRL | 10-Q | 1145985
2 | EX-10.1 | thomsenemploymentseparatio.htm | EX-10.1 | 57815
3 | EX-10.2 | ar2017performanceincentive.htm | EX-10.2 | 136714
4 | EX-31.1 | nktr2023-06x30xexx311.htm | EX-31.1 | 9424
5 | EX-31.2 | nktr2023-06x30xexx312.htm | EX-31.2 | 9417
6 | EX-32.1 | nktr2023-06x30xexx321.htm | EX-32.1 | 5793
12 |  | nektarlogoa.jpg | GRAPHIC | 14659
| Complete submission text file | 0000906709-23-000012.txt |  | 6019374

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nktr-20230630.xsd | EX-101.SCH | 42396
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nktr-20230630_cal.xml | EX-101.CAL | 64191
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nktr-20230630_def.xml | EX-101.DEF | 197182
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nktr-20230630_lab.xml | EX-101.LAB | 550092
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nktr-20230630_pre.xml | EX-101.PRE | 360409
57 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20230630_htm.xml | XML | 749214

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 231152772
SIC: 2834 Pharmaceutical Preparations